Objective To observe the effect of FTY720 and ICAM-1 mAb mono and combination therapy in cardiac allo-transplantation in rats. Methods Rats were randomly assigned to 9 groups, heart allo-transplantation were performed in abdominal site with micro-surgical technique. Recipients with allografts were treated with different doses of FTY720 and (or) ICAM-1 mAb. Graft survival, histopathology and level of serum IL-2, IFN-γ, IL-4, IL-10 were investigated. Results Low doses of FTY720 (1mg/kg) combined with ICAM-1 mAb achieved synergistic effect in the prolongation of cardiac graft survival, combination index(CI)=0.67. Conclusion Concomitant therapy of FTY720 and ICAM-1 mAb achieved a synergistic effect in the prolongation of heart allograft survival in rats.
FTY720 ICAM-1 mAb synergy rat heart transplantation immune tolerance rejection
This is a preview of subscription content, log in to check access.
XIONG Hai-bo, WEN Hao. Comparison of rat allocardiac transplantation model in cervical and abdominal site [J]. Journal of XingJiang Medical University, 2003, 26(4): 355–357.MathSciNetGoogle Scholar
Billingham M E, Cary N R, Hammond M E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group [J]. J Heart Transplant, 1990, 9(6): 587–593.Google Scholar
Chou T C. The median-effect principle and combination index for quantitation of synergism and antagonism[A]. Chou T C, Rideout D. Synergism and Antagonism in Chemotherapy[C]. San Diego: Academic Press, 1991.Google Scholar
Kimura T, Hasegawa T, Nakai H, et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells [J]. Transplantation, 2003, 75(9): 1469–1474.CrossRefGoogle Scholar
Chiba K, Hoshino Y, Ohtsuki M, et al. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. prevention of allograft rejection inrats and dogs by FTY720 and FTY720-phosphate [J]. Transplant Proc, 2005, 37(1): 102–106.CrossRefGoogle Scholar
Pinschewer D D, Ochsenbein A F, Odermatt B, et al. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory [J]. J Immunol, 2000, 164 (1): 5761–5770.CrossRefGoogle Scholar
Hoshino Y, Yanagawa Y, Ohtsuki M, et al. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK506 in rat allograft models[J]. Transplant Proc, 1999, 31(1–2): 1224–1226.CrossRefGoogle Scholar
Grochowiecki T, Gotoh M, Dono K, et al. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway [J]. Transplantation, 2000, 69(8): 1567–1571.CrossRefGoogle Scholar
Isobe M, Yagita H, Okumura K, et al. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1[J]. Science, 1992, 255(5048): 1125–1127.CrossRefGoogle Scholar
Pietersz G A, Sandrin M S, Ling S, et al. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival[J]. Transpl Immunol, 2001, 9(1): 7–11.CrossRefGoogle Scholar
Saggi B H, Fisher R A, Bu D, et al. Intra-graft cytokine expression and tolerance induction in rat renal allografts[J]. Transplantation, 1999, 67(2): 206–210.CrossRefGoogle Scholar